New Results
Preclinical establishment of a divalent vaccine against SARS-CoV-2
Zsofia Hevesi, Daniela Gerges, Sebastian Kapps, Raimundo Freire, Sophie Schmidt, Daniela D. Pollak, Klaus Schmetterer, Tobias Frey, Rita Lang, Wolfgang Winnicki, Alice Schmidt, Tibor Harkany, Ludwig Wagner
doi: https://doi.org/10.1101/2022.02.10.479919
Zsofia Hevesi
2Center for Brain Research, Medical University of Vienna, Vienna, Austria
Daniela Gerges
1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Sebastian Kapps
1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Raimundo Freire
3Unidad de Investigacion, Hospital Universitario de Canarias-FIISC, La Laguna, Tenerife, Spain
4Instituto de Tecnologías Biomedicas, Universidad de La Laguna, La Laguna, Tenerife, Spain
5Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain
Sophie Schmidt
1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Daniela D. Pollak
6Department of Neurophysiology and Neuropharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
Klaus Schmetterer
7Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
Tobias Frey
7Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
Rita Lang
8Division of Endocrinology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Wolfgang Winnicki
1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Alice Schmidt
1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Tibor Harkany
2Center for Brain Research, Medical University of Vienna, Vienna, Austria
9Department of Neuroscience, Biomedicum 7D, Karolinska Institutet, Solna, Sweden
Ludwig Wagner
1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Article usage
Posted February 10, 2022.
Preclinical establishment of a divalent vaccine against SARS-CoV-2
Zsofia Hevesi, Daniela Gerges, Sebastian Kapps, Raimundo Freire, Sophie Schmidt, Daniela D. Pollak, Klaus Schmetterer, Tobias Frey, Rita Lang, Wolfgang Winnicki, Alice Schmidt, Tibor Harkany, Ludwig Wagner
bioRxiv 2022.02.10.479919; doi: https://doi.org/10.1101/2022.02.10.479919
Preclinical establishment of a divalent vaccine against SARS-CoV-2
Zsofia Hevesi, Daniela Gerges, Sebastian Kapps, Raimundo Freire, Sophie Schmidt, Daniela D. Pollak, Klaus Schmetterer, Tobias Frey, Rita Lang, Wolfgang Winnicki, Alice Schmidt, Tibor Harkany, Ludwig Wagner
bioRxiv 2022.02.10.479919; doi: https://doi.org/10.1101/2022.02.10.479919
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)